Literature DB >> 22840886

Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database.

Ishan Hirji1, Susan W Andersson, Zhenchao Guo, Niklas Hammar, Andres Gomez-Caminero.   

Abstract

The objective of this population-based study was to evaluate the incidence of vaginitis (females) and balanitis (males) among a cohort of type 2 diabetes patients and compare this risk to patients without diabetes. The study population included 125,237 female patients and 146,603 males identified from GPRD. All patients were followed for 1-year from their study index date for the first record of an infection or a censored event. Among patients with diabetes the incidence of vaginitis was 21.0/1000PY (95% CI 19.8-22.1) with the risk being 1.81 (95% CI 1.64-2.00) greater that patients without diabetes. The incidence of balanitis among diabetes patients was 8.4/1000PY (95% CI 7.8-9.1) with a relative risk of 2.85 (2.39-3.39) compared to patients without diabetes. Additional analyses were performed by HbA1c level. Results from this large population-based study indicate that patients with diabetes are at an increased risk of being diagnosed with infections of the genital tract and patients with poorly controlled diabetes have higher risks.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840886     DOI: 10.1016/j.jdiacomp.2012.06.012

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  16 in total

1.  Balanitis is a risk factor for herpes zoster.

Authors:  C-Y Hsu; C-L Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-18       Impact factor: 3.267

Review 2.  Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.

Authors:  Giuseppe Defeudis; Rossella Mazzilli; Marta Tenuta; Giovanni Rossini; Virginia Zamponi; Soraya Olana; Antongiulio Faggiano; Paolo Pozzilli; Andrea M Isidori; Daniele Gianfrilli
Journal:  Diabetes Metab Res Rev       Date:  2021-09-21       Impact factor: 8.128

Review 3.  Genitourinary infection in diabetes.

Authors:  Sandeep Julka
Journal:  Indian J Endocrinol Metab       Date:  2013-10

4.  Risk of Vaginal Infections at Early Gestation in Patients with Diabetic Conditions during Pregnancy: A Retrospective Cohort Study.

Authors:  Julian Marschalek; Alex Farr; Herbert Kiss; Michael Hagmann; Christian S Göbl; Marie-Louise Trofaier; Verena Kueronya; Ljubomir Petricevic
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

5.  Diabetes and the occurrence of infection in primary care: a matched cohort study.

Authors:  Waseem Abu-Ashour; Laurie K Twells; James E Valcour; John-Michael Gamble
Journal:  BMC Infect Dis       Date:  2018-02-05       Impact factor: 3.090

Review 6.  Metabolic and hemodynamic effects of sodium-dependent glucose cotransporter 2 inhibitors on cardio-renal protection in the treatment of patients with type 2 diabetes mellitus.

Authors:  Atsunori Kashiwagi; Hiroshi Maegawa
Journal:  J Diabetes Investig       Date:  2017-05-12       Impact factor: 4.232

Review 7.  Benefits/risks of sodium-glucose co-transporter 2 inhibitor canagliflozin in women for the treatment of Type 2 diabetes.

Authors:  Pamela Kushner
Journal:  Womens Health (Lond)       Date:  2016-02-29

8.  Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial.

Authors:  J Rosenstock; A Jelaska; C Zeller; G Kim; U C Broedl; H J Woerle
Journal:  Diabetes Obes Metab       Date:  2015-07-14       Impact factor: 6.577

9.  Incidence and risk of vaginal candidiasis associated with sodium-glucose cotransporter 2 inhibitors in real-world practice for women with type 2 diabetes.

Authors:  Hiroki Yokoyama; Ami Nagao; Sanae Watanabe; Jun Honjo
Journal:  J Diabetes Investig       Date:  2018-10-19       Impact factor: 4.232

10.  Association of gestational diabetes mellitus and abnormal vaginal flora with adverse pregnancy outcomes.

Authors:  Xinhong Zhang; Qinping Liao; Fengying Wang; Dan Li
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.